Figure 3
Figure 3. BRG levels correlate with the proliferative activity of human acute myeloid leukemias (AMLs). (A) BAF gene expression in human AMLs and T-cell acute lympholastic leukemias (T-ALLs) based on adjusted reads by coverage obtained by RNA-seq. Mean values of 40 AMLs and 12 T-ALLs are shown. (B) BRG levels correlate with the proliferative activity of human AMLs based on adjusted reads by coverage obtained by RNA-seq. AMLs were ordered according to CDK4 expression levels. E2F1, PCNA, CDT1, and MCM2/3 proliferation-associated genes (PAGs) are used as comparative controls. Note that all AMLs had normal karyotypes, except leukemias identified as 07H160 and 10H068, which had monosomy 7 and 11p deletion, respectively. See also supplemental Tables 3-4.

BRG levels correlate with the proliferative activity of human acute myeloid leukemias (AMLs). (A) BAF gene expression in human AMLs and T-cell acute lympholastic leukemias (T-ALLs) based on adjusted reads by coverage obtained by RNA-seq. Mean values of 40 AMLs and 12 T-ALLs are shown. (B) BRG levels correlate with the proliferative activity of human AMLs based on adjusted reads by coverage obtained by RNA-seq. AMLs were ordered according to CDK4 expression levels. E2F1, PCNA, CDT1, and MCM2/3 proliferation-associated genes (PAGs) are used as comparative controls. Note that all AMLs had normal karyotypes, except leukemias identified as 07H160 and 10H068, which had monosomy 7 and 11p deletion, respectively. See also supplemental Tables 3-4.

Close Modal

or Create an Account

Close Modal
Close Modal